WallStreetZenWallStreetZen

NASDAQ: ALDX
Aldeyra Therapeutics Inc Stock Ownership - Who owns Aldeyra Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Aldeyra Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Perceptive Advisors LLC10% Owner2022-08-1015,000$7.85
$117.75kBuy
Perceptive Advisors LLC10% Owner2022-08-09100,000$7.50
$750.00kBuy
Perceptive Advisors LLC10% Owner2022-08-0897,000$7.24
$702.28kBuy
Perceptive Advisors LLC10% Owner2022-08-05141,000$6.95
$979.95kBuy
Perceptive Advisors LLC10% Owner2022-08-0495,100$6.17
$586.77kBuy
Perceptive Advisors LLC10% Owner2022-08-03100,000$5.84
$584.00kBuy
Perceptive Advisors LLC10% Owner2022-08-02412,406$5.59
$2.31MBuy
Perceptive Advisors LLC10% Owner2022-08-01144,185$5.05
$728.13kBuy
Perceptive Advisors LLC10% Owner2022-07-29222,123$5.03
$1.12MBuy
Perceptive Advisors LLC10% Owner2022-07-28119,392$5.00
$596.96kBuy

1 of 2

ALDX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALDX insiders and whales buy or sell their stock.

ALDX Shareholders

What type of owners hold Aldeyra Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC23.80%13,939,536$144.55MInsider
Perceptive Advisors LLC19.38%11,350,085$117.70MInstitution
Vanguard Group Inc4.27%2,499,161$25.92MInstitution
Knoll Capital Management LLC3.53%2,067,160$21.44MInstitution
Domain Partners Vi LP3.37%1,973,389$20.46MInsider
Jesse I. Treu3.22%1,885,854$19.56MInsider
Eagle Asset Management Inc3.15%1,844,010$19.12MInstitution
Johnson Johnson2.99%1,750,292$18.15MInsider
Verition Fund Management LLC2.67%1,565,028$16.23MInstitution
Todd C. Brady2.48%1,455,285$15.09MInsider

1 of 3

ALDX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALDX60.87%37.89%Net Buying
GHRS57.08%0.00%
MCRB69.78%30.22%Net BuyingNet Selling
ACRS67.30%32.70%Net SellingNet Buying
TYRA59.24%40.76%Net SellingNet Buying
View Top Biotech Stocks

Aldeyra Therapeutics Stock Ownership FAQ

Who owns Aldeyra Therapeutics?

Aldeyra Therapeutics (NASDAQ: ALDX) is owned by 60.87% institutional shareholders, 37.89% Aldeyra Therapeutics insiders, and 1.24% retail investors. Perceptive Advisors LLC is the largest individual Aldeyra Therapeutics shareholder, owning 13.94M shares representing 23.80% of the company. Perceptive Advisors LLC's Aldeyra Therapeutics shares are currently valued at $148.46M.

If you're new to stock investing, here's how to buy Aldeyra Therapeutics stock.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.